Propanc Biopharma (PPCB) Interest & Investment Income (2010 - 2025)
Propanc Biopharma (PPCB) posted quarterly Interest & Investment Income of $37.0 for Q4 2025, up 94.74% quarter-over-quarter from $19.0 in Q3 2025.
Propanc Biopharma (PPCB) Interest & Investment Income (2010 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Interest & Investment Income for 14 consecutive years, with $37.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Interest & Investment Income changed N/A year-over-year to $37.0; the TTM figure through Dec 2025 stood at $64.0 (up 128.57% YoY), while the FY2025 annual figure was $9.0, down 85.0% from the prior year.
- Interest & Investment Income grew to $37.0 in Q4 2025 per PPCB's latest filing, from $19.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $37.0 in Q4 2025 and bottomed at $1.0 in Q3 2024.
- Historically, Interest & Investment Income has averaged $13.42 across 4 years, with a median of $12.5 in 2023.
- On a YoY basis, Interest & Investment Income climbed as much as 1800.0% in 2025 and fell as far as 96.3% in 2025.
- Propanc Biopharma's Interest & Investment Income stood at $17.0 in 2022, then slipped by 5.88% to $16.0 in 2023, then plunged by 93.75% to $1.0 in 2024, then soared by 3600.0% to $37.0 in 2025.
- Business Quant data shows PPCB's Interest & Investment Income at $37.0 in Q4 2025, $19.0 in Q3 2025, and $7.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Propanc Biopharma | 587,855.41 | 587,855.41 | - | 37.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.00 |
| Sep 30, 2025 | 19.00 |
| Jun 30, 2025 | 7.00 |
| Mar 31, 2025 | 1.00 |
| Sep 30, 2024 | 1.00 |
| Mar 31, 2024 | 27.00 |
| Dec 31, 2023 | 16.00 |
| Sep 30, 2023 | 17.00 |
| Jun 30, 2023 | 9.00 |
| Mar 31, 2023 | 8.00 |
| Dec 31, 2022 | 17.00 |
| Sep 30, 2022 | 2.00 |
| Dec 31, 2020 | 1.00 |
| Jun 30, 2020 | 803.00 |
| Mar 31, 2020 | 137.00 |
| Dec 31, 2019 | 3.00 |
| Sep 30, 2019 | 3.00 |
| Jun 30, 2019 | 2.00 |
| Mar 31, 2019 | 2.00 |
| Dec 31, 2018 | 23.00 |